Fleming Erik S, Perkins James, Easa David, Conde Jose G, Baker Richard S, Southerland William M, Dottin Robert, Benabe Julio E, Ofili Elizabeth O, Bond Vincent C, McClure Shelia A, Sayre Michael H, Beanan Maureen J, Norris Keith C
Research Centers in Minority Institutions Translational Research Network, Charles R. Drew University of Medicine and Science, Los Angeles, California 90062, USA.
Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-155-60.
Translational research has tremendous potential as a tool to reduce health disparities in the United States, but a lack of common understanding about the scope of this dynamic, multidisciplinary approach to research has limited its use. The term "translational research" is often associated with the phrase "bench to bedside," but the expedited movement of biomedical advances from the laboratory to clinical trials is only the first phase of the translational process. The second phase of translation, wherein innovations are moved from the bedside to real-world practice, is equally important, but it receives far less attention. Due in part to this imbalance, tremendous amounts of money and effort are spent expanding the boundaries of understanding and investigating the molecular underpinnings of disease and illness, while far fewer resources are devoted to improving the mechanisms by which those advances will be used to actually improve health outcomes. To foster awareness of the complete translational process and understanding of its value, we have developed two complementary models that provide a unifying conceptual framework for translational research. Specifically, these models integrate many elements of the National Institutes of Health roadmap for the future of medical research and provide a salient conceptualization of how a wide range of research endeavors from different disciplines can be used harmoniously to make progress toward achieving two overarching goals of Healthy People 2010--increasing the quality and years of healthy life and eliminating health disparities.
转化研究作为一种减少美国健康差距的工具具有巨大潜力,但对于这种动态的、多学科研究方法的范围缺乏普遍认识,限制了其应用。“转化研究”一词常与“从实验室到病床旁”这一表述相关联,但生物医学进展从实验室快速推进到临床试验只是转化过程的第一阶段。转化的第二阶段,即创新从病床旁推广到实际应用中,同样重要,但却很少受到关注。部分由于这种不平衡,大量资金和精力被用于拓展对疾病分子基础的理解和研究,而用于改善这些进展实际用于改善健康结果的机制的资源则少得多。为了提高对完整转化过程的认识并理解其价值,我们开发了两个互补模型,为转化研究提供了一个统一的概念框架。具体而言,这些模型整合了美国国立卫生研究院医学研究未来路线图的许多要素,并对如何协调利用不同学科的广泛研究努力以朝着实现《2010年美国人健康目标》的两个总体目标——提高健康生活的质量和年限以及消除健康差距——取得进展进行了突出的概念化阐释。